Establishment of a comprehensive diagnostic model for neuromyelitis optica spectrum disorders based on the analysis of laboratory indicators and clinical data

W Jiang, X Yin, Y Wang, Y Ding, Y Pan, G Zheng… - Neurological …, 2023 - Springer
Background To establish a comprehensive diagnostic model for neuromyelitis optica
spectrum disorders (NMOSDs) based on laboratory indicators and clinical data. Methods A …

Relationship between the clinical characteristics in patients with neuromyelitis optica spectrum disorders and clinical immune indicators: A retrospective study

L Cai, Z Shi, H Chen, Q Du, Y Zhang, Z Zhao, J Wang… - Brain Sciences, 2022 - mdpi.com
Objective: T lymphocytes, complement, and immunoglobulin play an important role in
neuromyelitis optica spectrum disorders (NMOSD). As common clinical examination …

Predictive role of blood-based indicators in neuromyelitis optica spectrum disorders

X Fang, S Sun, T Yang, X Liu - Frontiers in Neuroscience, 2023 - frontiersin.org
Introduction This study aimed to assess the predictive role of blood markers in neuromyelitis
optica spectrum disorders (NMOSD). Methods Data from patients with NMOSD, multiple …

Epidemiology of neuromyelitis optica spectrum disorder in Tehran, Iran: the prevalence, baseline characteristics, and clinical aspects

N Rezaeimanesh, MA Sahraian, AN Moghadasi… - Neurological …, 2020 - Springer
Dear Editor, The prevalence of neuromyelitis optica spectrum disorder (NMOSD) is growing
in the world [1]. Despite increasing studies about NMOSD epidemiology, incidence and …

The 2015 IPND criteria increases the yield in diagnosis of neuromyelitis optica spectrum disorder in thai patients compared to the 2006 diagnostic criteria

N Rattanathamsakul, C Kaveeta, S Siritho… - Multiple Sclerosis and …, 2020 - Elsevier
Abstract Background The 2015 International Panel for Neuromyelitis Optica (NMO)
Diagnosis (IPND) criteria was revised using systematic literature reviews and consensus …

Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders

Q Du, Z Shi, H Chen, Y Zhang, J Wang, Y Qiu… - Journal of …, 2021 - Elsevier
Background At present, patients positive for aquaporin-4 antibody (AQP4-Ab) or myelin
oligodendrocyte glycoprotein antibody (MOG-Ab) are diagnosed as neuromyelitis optica …

Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients

MA Kanikannan, PK Arepareddy… - Multiple Sclerosis and …, 2019 - Elsevier
Abstract Background Neuromyelitis Optica spectrum disorders (NMOSD) are one of the most
common CNS demyelinating disorders as they will present with disabling recurrent …

Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus

M Sepúlveda, T Armangué, N Sola-Valls… - Neuroimmunology & …, 2016 - AAN Enterprises
Objective: To (1) determine the value of the recently proposed criteria of neuromyelitis optica
(NMO) spectrum disorder (NMOSD) that unify patients with NMO and those with limited …

Distinctive characteristics of early-onset and late-onset neuromyelitis optica spectrum disorders

LJ Zhang, LN Yang, T Li, J Wang, Y Qi… - International Journal …, 2017 - Taylor & Francis
Objectives: Little is known about patients with neuromyelitis optica spectrum disorders
(NMOSD) as defined by onset age. This study aimed to analyze the different demographic …

Clinical and epidemiological features in neuromyelitis optica spectrum disorder

D Osswald, J De Seze, N Collongues… - Journal Francais D' …, 2020 - europepmc.org
INTRODUCTION: Neuromyelitis optica spectrum disorder (NMO-SD) has been recognized
for the past decade. Biomarkers such as anti-Aquaporin 4 antibodies (AQP4) and anti …